百洋转债

Search documents
百洋医药: 关于2025年第二季度可转换公司债券转股情况的公告
Zheng Quan Zhi Xing· 2025-07-02 16:06
Core Points - The announcement details the conversion of the company's convertible bonds into shares, with a total of 139,601 bonds converted into 519,476 shares by the end of Q2 2025 [1][3] - The current conversion price for the bonds is set at 25.36 RMB per share, following adjustments due to annual profit distribution [2][3] - The total remaining convertible bonds amount to 8,460,399, with a total face value of 84,603.99 million RMB [3][4] Convertible Bond Details - The company issued 8.6 million convertible bonds on April 14, 2023, with a face value of 100 RMB each, raising a total of 8,600 million RMB [1][2] - The initial conversion price was set at 27.64 RMB per share, which has been adjusted multiple times due to profit distributions [2][3] - The conversion period for the bonds is from October 20, 2023, to April 13, 2029 [2] Share Capital Changes - As of March 31, 2025, the total share capital was 525,619,310 shares, which increased to 525,619,476 shares by June 30, 2025, due to the conversion of bonds [4] - The proportion of restricted shares remains at 0.01%, while unrestricted shares account for 99.99% of the total share capital [4]
中证转债指数高开0.04%,开能转债、博俊转债涨超3%,金陵转债、百洋转债涨超2%;东时转债跌超3%,锦鸡转债、盟升转债跌超1%。
news flash· 2025-06-11 01:33
中证转债指数高开0.04%,开能转债、博俊转债涨超3%,金陵转债、百洋转债涨超2%;东时转债跌超 3%,锦鸡转债、盟升转债跌超1%。 ...